Investor
INVESTOR AB
CIK 0000889232 · filed 2026-05-15 · SEC filing
13F book
$15.1B
Positions
10
4 new · 6 sold
Largest name
67.3%
Astrazeneca Plc Ord · AZN
Est. mark
−$737.4M
Price effect on 6 names still held. Flow $10.2B.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Astrazeneca Plc Ord | AZN | 51.6M | $10.2B | 67.3% | — | New |
| Nasdaq, Inc. | NDAQ | 58.4M | $4.93B | 32.6% | −$735.4M | Added−$718.5M |
| MediWound Ltd. | MDWD | 872.1K | $14M | 0.1% | −$2.05M | Held |
| Cellebrite DI Ltd. | CLBT | 55K | $757.9K | 0.0% | — | New |
| Coherent Corp. | COHR | 3K | $714.6K | 0.0% | $160.9K | Cut−$392.8K |
| Kyivstar Group Ltd | — | 59.4K | $601.1K | 0.0% | — | New |
| Verizon Communications Inc | VZ | 11.3K | $567.3K | 0.0% | — | New |
| Corsair Gaming, Inc. | CRSR | 99.7K | $553.4K | 0.0% | −$38.9K | Cut−$187.4K |
| Whirlpool Corp | — | 4.7K | $253.4K | 0.0% | −$67.4K | Added−$13.5K |
| Biomarin Pharmaceutical Inc | BMRN | 3.7K | $209K | 0.0% | −$10.9K | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.